RxDoctor Payments Data

Jeffrey Hargraves, PA

Physician Assistant · Coeur D Alene, IDNPI 1053040493

Payments from drug & device makers

$1,174in general payments, 2019–2025

Across 54 payments — averaging $21.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$247
  • Pfizer$130
  • Lilly USA, LLC$87
  • Otsuka America Pharmaceutical, Inc.$87
  • Dexcom, Inc.$57
  • Exact Sciences$54
  • plus $511 from 16 others

What the payments were for

  • Food & beverage$1,174100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,174 in reported general payments places this provider in the 75th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$2,153
Medicare patients
126
Services billed
269

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide66$99,353
JardianceEmpagliflozin84$81,491
TrulicityDulaglutide37$65,801
Trelegy ElliptaFluticasone/Umeclidin/Vilanter49$51,466
EliquisApixaban34$36,258
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$12,098
Breo ElliptaFluticasone/Vilanterol15$9,344
MyrbetriqMirabegron13$5,462
Venlafaxine Hcl ErVenlafaxine Hcl62$5,104
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$4,355
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl39$4,157
VascepaIcosapent Ethyl12$3,763
Fluticasone-SalmeterolFluticasone Propion/Salmeterol26$3,725
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen154$3,208
Duloxetine Hcl101$3,031

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$51$99,35366 claims
Boehringer IngelheimJardiance$31$81,49184 claims
Lilly USA, LLCTrulicity$87$65,80137 claims
PfizerEliquis$130$36,25834 claims
AbbVieSynthroid$247$1,03219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,027 physician assistant providers in Idaho.

Other physician assistant in Coeur D Alene

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →